IP Library Granted Patent US 7,790,655
Granted Patent B2
US 7,790,655 · App. 11/580,005 · Granted Sep 7, 2010

Cell display of antibody libraries

Assignee: MedImmune, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,655
App. No.
11/580,005
Granted
Sep 7, 2010
Kind
B2
Abstract

The present invention relates to a viral vector encoding for a library of antibodies or antibody fragments that are displayed on the cell membrane when expressed in a cell. The present invention provides cells comprising the viral vector nucleic acids and methods of screening the libraries for antibodies or antibody fragments with desired characteristics.

Claims (21)

1. A method for producing a library of cells displaying antibodies or fragments thereof on the cell surface comprising:

a. introducing into a population of cells a library of vectors encoding recombinant antibodies or fragments thereof that are displayed on the extracellular surface of the cell membrane; and

b. culturing the population of cells under conditions that allow expression of the antibodies or fragments thereof on the cell surface,

wherein the population of cells is a population of mammalian cells and wherein said antibodies or fragments thereof comprise the amino acid sequence of SEQ ID NO: 60.

2. The method of claim 1 , wherein the amino acid sequence of SEO ID NO: 60 is fused to the C-terminal end of the heavy chain or the light chain of the antibody.

3. The method of claim 1 , wherein said antibodies or fragments thereof are of an immunoglobulin type selected from the group consisting of IgA, IgE, IgM, IgD, IgY and IgG.

4. The method of claim 1 , wherein said antibodies or fragments thereof are murine antibodies, chimeric antibodies, humanized antibodies or human antibodies.

5. The method of claim 1 , wherein said antibodies or fragments thereof comprise an Fc region, wherein the Fc region is a naturally occurring Fc region or a variant Fc region comprising at least one amino acid substitution, insertion, deletion or combination thereof.

6. The method of claim 1 , wherein said antibodies or fragments thereof comprise a heavy chain variable region, a light chain variable region or both a heavy chain and a light chain variable region.

7. The method of claim 1 , wherein the mammalian cells are selected from the group consisting of NS0 cells, CHO cells, Vero cells, COS7 cells, and 293 cells.

8. The method of claim 1 , wherein said vectors are viral vectors.

9. The method of claim 8 , wherein said vectors are adenoviral vectors, adeno associated viral vectors, herpes viral vectors or lentiviral vectors.

10. A method of displaying a library of antibodies or fragments thereof on the cell surface comprising:

a. introducing into a population of cells a library of vectors encoding recombinant antibodies or fragments thereof wherein said antibodies or fragments thereof comprise the amino acid sequence of SEO ID NO: 60; and

b. culturing the population of cells under conditions that allow expression of the antibodies or fragments thereof on the cell surface,

wherein the population of cells is a population of mammalian cells.

11. The method of claim 10 , wherein the mammalian cells are selected from the group consisting of NS0 cells, CHO cells, Vero cells, COS7 cells, and 293 cells.

12. The method of claim 10 , wherein said antibody or fragment thereof is of an immunoglobulin type selected from the group consisting of IgA, IgE, IgM, IgD, IgY and IgG.

13. The method of claim 10 , wherein said antibody or fragment thereof is a murine antibody, chimeric antibody, humanized antibody or human antibody.

14. The method of claim 10 , wherein said antibody or fragment thereof comprises an Fc region, wherein the Fc region is a naturally occurring Fc region or a variant Fc region comprising at least one amino acid substitution, insertion, deletion or combination thereof.

15. The method of claim 10 , wherein the amino acid sequence of SEQ ID NO: 60 is fused to the C-terminal end of the heavy chain or the light chain of the antibody.

Assignments (2)
CHANGE OF NAME Recorded Sep 16, 2008
From: MEDIMMUNE, INC.
To: MEDIMMUNE, LLC
Reel/Frame 021536/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2007
From: GAO, CHANGSHOU; WU, HERREN
To: MEDIMMUNE, INC.
Reel/Frame 018857/0440 →
Continuity (2)
Provisional Application 6072616100 · Oct 14, 2005
Related Publication 20070111260A1 · May 17, 2007